Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2− and ER+HER2+) breast cancers-Reference-Cited by-同舟云学术

Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2− and ER+HER2+) breast cancers

Published:2017-06 Issue: Volume:170 Page:65-74
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Kanaya Noriko,Somlo George,Wu Jun,Frankel Paul,Kai Masaya,Liu Xueli,Wu Shang Victoria,Nguyen Duc,Chan Nymph,Hsieh Meng-Yin,Kirschenbaum Michele,Kruper Laura,Vito Courtney,Badie Behnam,Yim John H.,Yuan Yuan,Hurria Arti,Peiguo Chu,Mortimer Joanne,Chen Shiuan

Funder

Nicola Solomon

Catherine Scher and Sylvana Salvatierrafor obtaining samples from COH tumor banks

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Patient-derived tumour xenografts as models for breast cancer drug development;Marangoni;Curr. Opin. Oncol.,2014

2. Patient-derived xenograft models: an emerging platform for translational cancer research;Hidalgo;Cancer Discov.,2014

3. Prioritizing therapeutic targets using patient-derived xenograft models;Lodhia;Biochim. Biophys. Acta,2015

4. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response;Gao;Nat. Med.,2015

5. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology: growth, metastasis and disease outcomes;DeRose;Nat. Med.,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular features of luminal breast cancer defined through spatial and single‐cell transcriptomics;Clinical and Translational Medicine;2024-01

2. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms;Journal of Biological Chemistry;2023-08

3. Identification and characterization of a proliferative cell population in estrogen receptor-positive metastatic breast cancer through spatial and single-cell transcriptomics;2023-02-03

4. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors;Cancers;2022-12-30

5. Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models;Molecular Cancer Research;2022-03-11